Research analysts at StockNews.com started coverage on shares of GlycoMimetics (NASDAQ:GLYC – Get Free Report) in a research note issued on Thursday. The firm set a “sell” rating on the biotechnology ...

In March 2025, Akeso initiated an open-label, Phase Ib/II study involving patients diagnosed with acute myeloid leukemia (AML ...

The rumors turned out to be correct, even if most were styling it with a capital E rather than a lower-case one: the iPhone SE 4 is officially named the iPhone 16e. One question is what the e ...

I’m concerned less with the “e” (which, I’m sure, doesn’t stand for any one thing, though Apple would probably be plenty happy if it was interpreted as for “efficiency”) than with ...

It develops uproleselan, an E-selectin antagonist, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as completed phase 3 trial to treat relapsed ...

Investigating clinical associations between genomic alterations and prostate cancer lineage states using circulating tumor cell RNA sequencing. This is an ASCO Meeting Abstract from the 2025 ASCO ...

Investopedia / Matthew Collins Euler’s number (e), 2.71828..., is one of the most important constants in mathematics. It's a non-repeating number that never ends. It's found in many contexts ...

Selectins are a group of Ca 2+-dependent, transmembrane type I glycoproteins which attract cell adhesion and migration. E-selectin is exclusively expressed in endothelial cells, and its expression is ...

8 P-selectin is expressed on endothelial cells and activated platelets to recruit leukocytes to the sites of endothelial injury and has been hypothesized to play a key role in mediating the ...

The sLE x carbohydrate moiety binds to both P and E selectin. In the lung injury model, the enhanced protective effect of sCR1sLE x correlated with increased binding of sCR1sLe x to the lung ...